Beijing Leadman Biochemistry Co Ltd. Stock Analysis 300289.SZ

Beijing Leadman Biochemistry Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. The company is headquartered in Beijing, Beijing and currently employs 420 full-time employees. The company went IPO on 2012-02-16. The firm's products primarily include four categories. The vitro diagnostic reagents include biochemical diagnostic reagents and immunodiagnostic reagents, and are mainly used for auxiliary diagnosis of diseases such as liver disease, kidney disease, cardiovascular disease, diabetes, immune disease, metabolic disease, pancreatitis, coagulation and fibrinolysis disorders. The diagnostic instrument products primarily include the CI 2000 S, CI1200, and CI1200 P series of fully automatic chemiluminescence immunoassays. The biochemical raw materials include enzymes, coenzymes, antigens, antibodies, and other reagents. The firm primarily conducts its businesses in domestic market.